Cargando…

Antiretroviral Treatment for HIV Elite Controllers?

In most HIV-infected persons, the natural history of untreated infection is one of sustained viremia, progressive CD4 T cell depletion with resultant morbidity and mortality. The advent of effective combination antiretroviral therapy (ART) that controls HIV replication has altered this landscape dra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ruiz-Mateos, Ezequiel, Poveda, Eva, Lederman, Michael M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Pathogens and Immunity 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7307444/ https://www.ncbi.nlm.nih.gov/pubmed/32582872 http://dx.doi.org/10.20411/pai.v5i1.364

Ejemplares similares

Interleukin 18 (IL-18) and IL-3 in Extracellular Vesicles: Biomarkers for Durable Elite Control of HIV-1
por: Poveda, Eva, et al.
Publicado: (2023)

Long-term Persistent Elite HIV-controllers: The Right Model of Functional Cure
por: Tarancon-Diez, Laura, et al.
Publicado: (2018)

Role of APOBEC3H in the Viral Control of HIV Elite Controller Patients
por: Benito, José M., et al.
Publicado: (2018)

Multimodal Investigation of Neuroinflammation in Aviremic Patients With HIV on Antiretroviral Therapy and HIV Elite Controllers
por: Sari, Hasan, et al.
Publicado: (2022)

Blunted Response to Combination Antiretroviral Therapy in HIV Elite Controllers: An International HIV Controller Collaboration
por: Boufassa, Faroudy, et al.
Publicado: (2014)

Immune Correlates of Natural HIV Elite Control and Simultaneous HCV Clearance—Supercontrollers
por: Dominguez-Molina, Beatriz, et al.
Publicado: (2018)

Immunometabolism is a key factor for the persistent spontaneous elite control of HIV-1 infection
por: Tarancon-Diez, Laura, et al.
Publicado: (2019)

Different profiles of immune reconstitution in children and adults with HIV-infection after highly active antiretroviral therapy
por: Resino, Salvador, et al.
Publicado: (2006)

Permanent control of HIV-1 pathogenesis in exceptional elite controllers: a model of spontaneous cure
por: Casado, Concepcion, et al.
Publicado: (2020)

Evolution of Serum Acute-Phase Glycoproteins Assessed by (1)H-NMR in HIV Elite Controllers
por: Malo, Ana-Irene, et al.
Publicado: (2021)

An open label randomized controlled trial of atorvastatin versus aspirin in elite controllers and antiretroviral-treated people with HIV
por: Mystakelis, Harry A., et al.
Publicado: (2023)

Perforin Expression Directly Ex Vivo by HIV-Specific CD8(+) T-Cells Is a Correlate of HIV Elite Control
por: Hersperger, Adam R., et al.
Publicado: (2010)

Quantitative humoral profiling of the HIV-1 proteome in elite controllers and patients with very long-term efficient antiretroviral therapy
por: Zhang, Wang, et al.
Publicado: (2017)

Clinical outcomes and antiretroviral therapy in ‘elite’ controllers: a review of the literature
por: Crowell, Trevor A, et al.
Publicado: (2015)

Differences in serum IgA responses to HIV-1 gp41 in elite controllers compared to viral suppressors on highly active antiretroviral therapy
por: Nabi, Rafiq, et al.
Publicado: (2017)

Prospective Antiretroviral Treatment of Asymptomatic, HIV-1 Infected Controllers
por: Hatano, Hiroyu, et al.
Publicado: (2013)

The many faces of HIV elite control
por: Tiemessen, Caroline T.
Publicado: (2021)

Class-modeling analysis reveals T-cell homeostasis disturbances involved in loss of immune control in elite controllers
por: Benito, José M., et al.
Publicado: (2018)

CD161 Expression on Mucosa-Associated Invariant T Cells is Reduced in HIV-Infected Subjects Undergoing Antiretroviral Therapy Who Do Not Recover CD4(+) T Cells
por: Freeman, Michael L., et al.
Publicado: (2017)

Comprehensive analysis of HIV reservoirs in elite controllers
por: Kennedy, Brooke D., et al.
Publicado: (2023)

Elite control of HIV infection: implications for vaccines
por: Pereyra, Florencia, et al.
Publicado: (2006)

Contestation of Elite Discourse in Treatment of HIV and AIDS
por: ARWAN, Arwan, et al.
Publicado: (2019)

Late HIV Diagnosis but Earlier Antiretroviral Treatment Initiation in Northwest Spain: Impact of Current Treatment Guidelines
por: Cid-Silva, Purificación, et al.
Publicado: (2019)

Elite and posttreatment controllers, two facets of HIV control
por: Mastrangelo, Andrea, et al.
Publicado: (2022)

Raymond Schinazi Discusses the Discovery of Early Antiretroviral Agents and Sofosbuvir
por: Lederman, Michael M., et al.
Publicado: (2023)

Altered Monocyte Phenotype in HIV-1 Infection Tends to Normalize with Integrase-Inhibitor-Based Antiretroviral Therapy
por: McCausland, Marie R., et al.
Publicado: (2015)

Attenuation of multiple Nef functions in HIV-1 elite controllers
por: Mwimanzi, Philip, et al.
Publicado: (2013)

New Antiretroviral Treatment for HIV
por: Badowski, Melissa E., et al.
Publicado: (2016)

Expression profile of host restriction factors in HIV-1 elite controllers
por: Abdel-Mohsen, Mohamed, et al.
Publicado: (2013)

Elite and viremic HIV-1 controllers in West Africa
por: N’takpé, Jean Baptiste, et al.
Publicado: (2022)

Elite controllers: A heterogeneous group of HIV-infected patients
por: Navarrete-Muñoz, María A., et al.
Publicado: (2020)

Short-term maraviroc exposure, a clinical approach to decide on maraviroc prescription in HIV-1-infected treatment-naïve patients
por: Gonzalez-Serna, Alejandro, et al.
Publicado: (2016)

Massive Release of CD9(+) Microvesicles in Human Immunodeficiency Virus Infection, Regardless of Virologic Control
por: Poveda, Eva, et al.
Publicado: (2020)

γδT cells are ADCC effectors in elite HIV controllers
por: Poonia, Bhawna, et al.
Publicado: (2010)

Differential miRNA plasma profiles associated with the spontaneous loss of HIV‐1 control: miR‐199a‐3p and its potential role as a biomarker for quick screening of elite controllers
por: Masip, Jenifer, et al.
Publicado: (2021)

The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial
por: Gandhi, Rajesh T., et al.
Publicado: (2010)

Development of Immature CD4(+)CD8(+)T Cells Into Mature CD4(+) T Cells Requires Alpha-1 Antitrypsin as Observed by Treatment in HIV-1 Infected and Uninfected Controls
por: Bristow, Cynthia L., et al.
Publicado: (2019)

S03-06 OA. Rapid perforin upregulation by CD8 T cells in elite controllers as a correlate of immune-mediated control of HIV replication
por: Hersperger, AR, et al.
Publicado: (2009)

A unique viral reservoir landscape in HIV-1 elite controllers
por: Jiang, Chenyang, et al.
Publicado: (2020)

Nationwide Study of Drug Resistance Mutations in HIV-1 Infected Individuals under Antiretroviral Therapy in Brazil
por: Santos-Pereira, Ana, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vgbm7ta8pn8hjssv908f8sq3t6